Highlights Spectral Medical Inc.

Equities

EDT

CA8475771033

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 02:30:00 07/02/2026 am IST			5-day change	1st Jan Change
1.300 ^CAD	0.00%		+4.00%	-9.72%

10/12	Spectral Medical Inc. - Special Call
07/11	Spectral Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Highlights

07/11	Spectral Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
07/11	Spectral Medical Provides Update on PMX Submission to FDA, Also Reports Q3 Loss	MT
07/11	Spectral Medical Brief: Says PMA Submission Targeted for Q1 2026 Following "Positive" Tigris results and ongoing FDA interactions	MT
07/11	Spectral Medical Brief: Total Q3 Revenue Increased to $675,000 compared to $502,000 for the same period in 2024	MT
07/11	Spectral Medical Q3 revenue up 34%	RE
16/25/16	Spectral Medical Provides Observational Study Update	MT
16/25/16	Spectral Medical Inc. Announces Publication of Eden Observational Study	CI
25/25/25	Spectral Medical Receives US$3 Million From Vantive	MT
25/25/25	Spectral Medical Brief: Says Received US$3 Million From Vantive	MT
13/25/13	Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock	CI
08/25/08	Spectral Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
08/25/08	Spectral Medical Q2 Loss Narrows	MT
08/25/08	Spectral Medical announces second quarter and provides corporate update	RE
08/25/08	Earnings Flash (EDT.TO) Spectral Medical Inc. Reports Q2 Revenue C$0.8M	MT
05/25/05	Spectral Medical Brief: Announcing Filing of Base Shelf Prospectus	MT
09/25/09	Spectral Medical Q1 Loss Triples on Fair Value Adjustments	MT
09/25/09	Spectral Medical Brief: Entering Into An Up to US$10 Million Promissory Note with Vantive to Fund Spectral to PMX commercialization	MT
09/25/09	Spectral Medical Brief: Says Tigris Trial Enrollment Completed; Topline Results Expected to be Released In August 2025	MT
09/25/09	Spectral Medical Brief: Q1 Loss $12.605 Million Or $0.04 Per Share	MT
09/25/09	Spectral Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
16/25/16	Spectral Medical Inc. Completes Tigris Trial Enrollment	CI
27/25/27	Spectral Medical Swing to Q4 Loss, Revenue Advances	MT
27/25/27	Spectral Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
27/25/27	Earnings Flash (EDT.TO) Spectral Medical Posts Q4 Revenue C$645,000	MT
27/25/27	Spectral Medical Announces Fourth Quarter And Fiscal 2024 Results And Provides Corporate Update	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Spectral Medical Inc.

Equities

EDT

CA8475771033

Pharmaceuticals

Highlights

Filters